Exagen Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for XGN, updated each market day.
XGN AI Sentiment
AI sees no strong directional signal for Exagen Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Exagen Inc. Common Stock
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Sector
Exchange
Market Cap
$74,323,949
Cap Tier
Employees
220
Headquarters
VISTA, CA
Listed Since
Sept. 19, 2019
Website
XGN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
XGN Volatility
Exagen Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
